Castle Hill, Australia
Beyond 700 is a Sydney based start-up company in the biotechnology and health care industries. Their slogan "See the invisible" aptly describes their commitment to developing optoelectronic technology for new applications in biology and medicine. Founded in 2017, the company aims to address unmet needs by making visible what is currently undetectable in scientific and medical realms. Their first product, TearView, a medical device, has the potential to revolutionize clinical eye care by enabling specialists to visualize previously invisible diseases on the eye's surface.
The company received a Seed Round investment on 14 October 2018 from Cicada Innovations, signifying the initial backing of their vision. Beyond 700's ambition to cater to global markets while proudly manufacturing their product in Sydney aligns with their goal to offer improved solutions for biomedical and scientific challenges. With a promising start, Beyond 700 has paved the way for further innovations in the field and demonstrates potential for exponential growth as it continues to fulfill its vision of making the invisible visible.
